Product ID: SQMIG35G2215
Global Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product(Reagents, Kits), By Test(Laboratory, POC), By Technology(Immunodiagnostics, Microbiology), By Disease(COVID-19, Hepatitis), By End-user(Diagnostic Laboratories, Hospitals & Clinics) - Industry Forecast 2024-2031
Report ID:
SQMIG35G2215 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|
Tables:
154 |
Figures:
77
Global Infectious Disease Diagnostics Market Dynamics
Infectious Disease Diagnostics Market Driver
- The prevalence of infectious diseases in developed and developing regions will have a positive impact on the infectious disease diagnostics market. The increasing number of prescriptions for infectious disease diagnostic tests is attributable to the diagnosis and management of such diseases. These factors, combined with the growing trend toward preventive medicine, are expected to drive demand for infectious disease diagnostics over the forecast period.
- The increasing prevalence of infectious diseases, the shift in focus from centralized laboratories to point-of-care testing, and increased R&D activities on infectious disease diagnostics are the major factors driving the Infectious Disease Diagnostics Market growth. Scientific R&D activities in developing novel technologies and techniques such as mass spectrometry and next-generation sequencing (NGS) are changing the way rapid diagnostics are performed to detect diseases, which is contributing to Infectious Disease Diagnostics Market growth.
- Developing economies such as India, South Korea, Brazil, and Mexico are expected to provide opportunities for growth for major players in the infectious disease diagnostics market. This can be attributed to these countries' high disease prevalence, large patient population, improved healthcare infrastructure, rising disposable income, and growing medical tourism.
Infectious Disease Diagnostics Market Restraint
- Inadequate reimbursement is a major impediment to the infectious disease diagnostics market's growth. Most diagnostic companies face a significant challenge in commercializing their tests: getting health insurers to pay for them. Moreover, in developing countries, a large proportion of the global population is infected with infectious diseases such as HIV, malaria, and tuberculosis. Lack of training among clinicians and poor product accessibility due to lower per capita expenditure have resulted in lower adoption of POC kits in low-middle income countries.
Global Infectious Disease Diagnostics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
